Evaluating the role of treatment-related toxicities in the challenges facing targeted therapies for advanced hepatocellular carcinoma.
about
Oncological Impact of M-Tor Inhibitor Immunosuppressive Therapy after Liver Transplantation for Hepatocellular Carcinoma: Review of the LiteratureA Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma CellsmiR-615-5p prevents proliferation and migration through negatively regulating serine hydromethyltransferase 2 (SHMT2) in hepatocellular carcinoma.Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis.The albumin-bilirubin grade improves hepatic reserve estimation post-sorafenib failure: implications for drug development.
P2860
Evaluating the role of treatment-related toxicities in the challenges facing targeted therapies for advanced hepatocellular carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Evaluating the role of treatme ...... nced hepatocellular carcinoma.
@ast
Evaluating the role of treatme ...... nced hepatocellular carcinoma.
@en
type
label
Evaluating the role of treatme ...... nced hepatocellular carcinoma.
@ast
Evaluating the role of treatme ...... nced hepatocellular carcinoma.
@en
prefLabel
Evaluating the role of treatme ...... nced hepatocellular carcinoma.
@ast
Evaluating the role of treatme ...... nced hepatocellular carcinoma.
@en
P2860
P1476
Evaluating the role of treatme ...... nced hepatocellular carcinoma.
@en
P2093
Daniel H Palmer
Phillip J Johnson
P2860
P2888
P304
P356
10.1007/S10555-015-9580-2
P577
2015-08-07T00:00:00Z